vimarsana.com

Liquid Biopsy Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dxcover Limited: Dxcover Raises $11 9m in Series A and Grant Funding to Accelerate Liquid Biopsy to Market

Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology

United statesUnited kingdomAndrew mcneillLauren arnoldMark hegartyMatthewj bakerThairm bioSchwierige zeitenMark bamforthMercia asset managementEuropean innovation councilMercia knowledge intensive impact fundUniversity of strathclydeNeos advisoryLiquid biopsy platformScottish enterprise

Dxcover Raises £9 7M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Glasgow cityUnited kingdomMark hegartyMatthewj bakerMark bamforthEuropean innovation councilUniversity of strathclydeUnited kingdom basedNeos advisoryMercia asset managementScottish enterpriseNorcliffe capitalEuropean innovationLiquid biopsy platformProfessor matthew

vimarsana © 2020. All Rights Reserved.